Press release | 25 April 2024 In precedent-setting move towards drug-development cost transparency, MSF reveals cost of its landmark TB clinical trial: €34 million MSF urges public and non-profit actors to publish clinical trial costs to improve access to medical products Tags TransparencyResearch and developmentTuberculosis tuberculosis
Technical brief | 25 April 2024 Transparency CORE: Clinical Trial Cost Reporting Toolkit A toolkit to facilitate the analysis and publication of clinical trial costs Tags TransparencyResearch and development
Technical brief | 11 November 2022 MSF Clinical Trial Transparency Policy This policy is a commitment to publishing research protocols, registering clinical trials on appropriate registries, and subsequently publishing clinical trial data in open access formats, in line with the WHO’s joint statement on ... Tags TransparencyResearch and development